CompletedPhase 2NCT00327171
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer
Studying Twin-reversed arterial perfusion sequence
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Principal Investigator
- ICD CSDSanofi
- Intervention
- Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)(drug)
- Enrollment
- 218 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2006 – 2010
Study locations (11)
- Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office, Macquarie Park, Australia
- Sanofi-Aventis Administrative Office, Laval, Canada
- Sanofi-Aventis Administrative Office, Paris, France
- Sanofi-Aventis Administrative Office, Berlin, Germany
- Sanofi-Aventis Administrative Office, Milan, Italy
- Sanofi-Aventis Administrative Office, Gouda, Netherlands
- Sanofi-Aventis Administrative Office, Porto Salvo, Portugal
- Sanofi-Aventis Administrative Office, Barcelona, Spain
- Sanofi-Aventis Administrative Office, Bromma, Sweden
- Sanofi-Aventis Administrative Office, Geneva, Switzerland
Collaborators
Regeneron Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00327171 on ClinicalTrials.govOther trials for Twin-reversed arterial perfusion sequence
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06550011Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)Avirmax Biopharma Inc
- RECRUITINGNCT06821919Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)Western Galilee Hospital-Nahariya
- ACTIVE NOT RECRUITINGNCT07194915Pleural Fluid Neutrophil Extracellular Traps Exacerbate Disease Severity and Risk of One-year Mortality in Pleural Infection (TORPIDS-3)University of Oxford
- RECRUITINGNCT06412822Neutrophil Extracellular Traps (NET's) in Prevalent Kidney StoneBrugmann University Hospital
- RECRUITINGNANCT05711173Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)University Hospital, Bordeaux
- ACTIVE NOT RECRUITINGNCT07185646Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast CancerSecond Xiangya Hospital of Central South University
- RECRUITINGNCT05056857Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking TamoxifenM.D. Anderson Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT04784416Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)NYU Langone Health
See all trials for Twin-reversed arterial perfusion sequence →